Older adults may lose less bone loss if they increase the alkali content of their diet, according to research released online in October in advance of publication in an upcoming issue of the Journal of Clinical Endocrinology & Metabolism.
Older adults may lose less bone loss if they increase the alkali content of their diet, according to research released online in October in advance of publication in an upcoming issue of the Journal of Clinical Endocrinology & Metabolism.
Bess Dawson-Hughes, MD, of Tufts University in Boston, and colleagues conducted a double-blind controlled trial of 162 individuals, aged 50 years and older. Participants were randomized to receive daily doses over 3 months of either potassium bicarbonate, sodium bicarbonate, potassium chloride, or placebo. Urinary excretion of calcium and the bone turnover marker N-telopeptide was measured at baseline and at the 3-month study conclusion. The investigators combined all patients receiving bicarbonate into one group, and all patients not receiving bicarbonate into another group for analysis.
Compared to baseline, urinary excretion of calcium and N-telopeptide at 3 months was significantly reduced among individuals receiving bicarbonate, but not among those not receiving bicarbonate. The investigators also reported that participants receiving bicarbonate had a 13.4 % decrease in urinary levels of the N-telopeptide to creatinine ratio. According to the study authors, this suggested that bicarbonate lowered bone resorption among these individuals.
The results of this study led the authors to conclude that "increasing intake of alkali merits further consideration as a safe and low-cost approach to improving skeletal health in older men and women."
Dawson-Hughes B, Harris SS, Palermo NJ, et al. Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women. J Clin Endocrinol Metabol, 2009;, No. 1 96-102 (online at doi:10.1210/jc.2008-1662)
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More